Abstract: Disclosed are antigen binding polypeptides and antigen binding polypeptide complexes (e.g., antibodies and antigen binding fragments thereof) having certain structural and/or functional features. Also disclosed are polynucleotides and vectors encoding such polypeptides and polypeptide complexes; host cells, pharmaceutical compositions and kits containing such polypeptides and polypeptide complexes; and methods of using such polypeptides and polypeptide complexes.

Abstract: A method and system for financing publicly traded companies. According to one embodiment, a client provides collateral for receiving financing. Such collateral includes, on one hand, pledged assets, for example, accounts receivable, equipment, inventory real estate and the like, and on the other hand, stock. The stock is transferred to an entity, such as a limited liability company (LLC). The stock may be liquidated throughout the term of the financing or upon default by the client. If the client defaults, the cash and stock are provided to the lending party; where the LLC is majority owned by the client and the client does not default, at the end of the term, the client has a funded financing company in the form of the LLC.